Phlebotomy Equipment Market Overview
As per MRFR analysis, the Phlebotomy Equipment Market Size was estimated at 7.85 (USD Billion) in 2022. The Phlebotomy Equipment Market Industry is expected to grow from 8.27 (USD Billion) in 2023 to 13.3 (USD Billion) by 2032. The Phlebotomy Equipment Market CAGR (growth rate) is expected to be around 5.42% during the forecast period (2024 - 2032).
Key Phlebotomy Equipment Market Trends Highlighted
The Phlebotomy Equipment Market has more principles in medicine than one might imagine, with factors such as the increased rates of blood tests, enhanced blood collection device design, and a greater understanding of proper handling of blood as the key contributors. Biopsy devices with innovative engineering features designed within the devices to eliminate possible errors have largely shielded patients from needless harm. According to the analysis, chronic diseases and increasing laparoscopic procedures along with diagnostic ones, bring the phlebotomy equipment’s necessity to the fore. Nonetheless, new opportunities are offered in the introduction of non-invasive blood collection contact angle blood collectors and bodily transdermal patch collectors. These devices are less painful to patients, thus allowing blood from patients to be collected at home for tests and in fields for faster action to be taken on patients. Laptop computers, complex programs of highly skilled personnel, and high-quality collection systems for blood aspirate movements rapidly formulate new trends in the field of phlebotomy. In addition, as home visits with technology and app monitoring of patients become more widespread, these will be the new avenues for blood collection and testing that will not require a central laboratory.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Phlebotomy Equipment Market Drivers
Technological Advancements Enhancing Accuracy and Efficiency
At present, the Phlebotomy Equipment Market Industry is experiencing a noteworthy trend over the surge in technological improvements, which have upended practices extensively. It is important to note that most of these trends are designed to specifically improve the accuracy and efficacy of blood collection procedures. In this light, the introduction of automated systems or software used for either collecting or regulating systems has advanced the process making the same less prone to human errors.In addition, the integration of a greater number of sensors with data analytics at the interface of the application has also enabled real-time recording of monitoring parameters for the same. Both these trends are expected to support the growth of the market in the upcoming years since the two offer several advantages that improve the functional efficacy of the equipment for clinicians.
Rising Prevalence of Chronic Diseases Fueling Demand for Phlebotomy Services
The increasing prevalence of chronic diseases worldwide is a major factor driving the growth of the Phlebotomy Equipment Market Industry. Conditions such as diabetes, cardiovascular diseases, and cancer require regular blood tests for monitoring and diagnosis. These tests often involve multiple blood draws, leading to an increased demand for phlebotomy services and equipment. As the global population ages and the incidence of chronic diseases continues to rise, the demand for phlebotomy equipment is expected to remain strong in the coming years.
Expansion of Point-of-Care Testing Driving Demand for Portable Phlebotomy Devices
The growing adoption of point-of-care testing (POCT) is another significant driver of the Phlebotomy Equipment Market Industry. POCT involves performing diagnostic tests at or near the patient's location rather than in a centralized laboratory. This trend is driven by the need for faster and more convenient testing, particularly in remote or underserved areas. Portable phlebotomy devices play a crucial role in POCT, as they allow healthcare professionals to collect blood samples outside of traditional clinical settings.The expansion of POCT is expected to continue fueling the demand for portable phlebotomy devices, as they offer greater flexibility and accessibility in blood collection.
Phlebotomy Equipment Market Segment Insights
Phlebotomy Equipment Market Product Type Insights
The Phlebotomy Equipment Market is classified based on product types and includes blood collection tubes, needles, syringes, blood collection bags, and safety lancets. As of 2023, blood collection tubes accounted for the highest revenue share as they are essential for collecting and retaining drawn blood samples. The market share for blood collection tubes will continue to grow as the demand for diagnostic tests and blood transfusions increases. The needle market share is also expected to grow due to the increased demand for blood tests and injection blood needles.In addition, phlebotomies syringes are important equipment needed to draw and receive fluid into the body and to withdraw fluids from the body. Syringes market share will remain consistent because of the diverse applications in the medical sector. The blood collection bags market share is also expected to grow as blood transfusions become more common. Safety lancets market share is expected to grow as point-of-care testing increases. Moreover, it is expected to be valued at USD 13.3 billion by 2032 due to increases in blood tests, blood transfusions, and injections.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Phlebotomy Equipment Market End User Insights
Hospitals held a dominant share in the Phlebotomy Equipment Market in 2023. The increasing number of surgeries, blood transfusions, and diagnostic tests in hospitals is driving the market growth. Hospitals are equipped with advanced phlebotomy equipment, such as vacuum blood collection systems, safety needles, and blood collection tubes, to ensure efficient and safe blood collection procedures. Moreover, the rising prevalence of chronic diseases, such as diabetes and cardiovascular diseases, has led to an increase in the number of blood tests, further supporting the growth of the phlebotomy equipment market in hospitals.
Phlebotomy Equipment Market Material Insights
The Material segment of the Phlebotomy Equipment Market is expected to witness significant growth in the coming years. Plastic is the most commonly used material in the manufacturing of phlebotomy equipment due to its cost-effectiveness, ease of molding, and lightweight properties. Glass is also widely used, particularly in the production of evacuated blood collection tubes due to its inertness and ability to maintain sample integrity. Stainless steel is another important material used in the production of needles, scalpels, and other surgical instruments due to its durability and resistance to corrosion.The increasing demand for phlebotomy services in hospitals, clinics, and diagnostic laboratories is driving the growth of the Material segment. Additionally, advancements in material technology, such as the development of new polymers and alloys, are expected to fuel further growth in the segment.
Phlebotomy Equipment Market Regional Insights
The regional segmentation of the Phlebotomy Equipment Market offers insights into the market's geographical distribution and growth potential. North America holds a significant market share, driven by advanced healthcare infrastructure, technological advancements, and increasing demand for phlebotomy services. Europe follows closely, with a well-established healthcare system and a growing focus on preventive healthcare. The APAC region is projected to witness substantial growth due to rising healthcare expenditure, increasing prevalence of chronic diseases, and government initiatives to improve healthcare access.South America and MEA present emerging markets with untapped potential, offering opportunities for market expansion.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Phlebotomy Equipment Market Key Players And Competitive Insights
The Phlebotomy Equipment Market is competitive as there are several established and emerging players constantly involved in product development. As a result, a leading player in the market are engaged in strategic collaborations, mergers and acquisitions to expand their geographical footprint and enhance their market share. The top players in the Phlebotomy Equipment Market are also focusing on product innovation to cater to every evolving requirement of healthcare professionals and patients. Owing to its highly competitive nature, the Phlebotomy Equipment Market is also likely to witness the introduction of new players. BD is a major global medical technology company offering a wide range of Phlebotomy Equipment Market products. The company offers a broad range of phlebotomy products that include needles, syringes, blood collection tubes and other blood collection accessories. The company is renowned for its high-quality products and commitment to innovation. BD’s products are used by healthcare professionals in more than 100 countries.Terumo Corporation is a premier global manufacturer of medical devices with various kinds of products, including needles, syringes, blood collection tubes, IV catheters, balloons and many others. Its blood collection product portfolio includes syringes, cups, and needles. Its Terumo PrecisionGlide is a high-quality blood collection needle that is greatly appreciated by healthcare professionals in various countries. Terumo Corporation operates in over 160 countries.Fresenius Kabi is a publicly traded company that is one of the leading providers of products for the healthcare industry, globally. The Company operates in eight business segments, including transfusion technology, Infusion therapy, Clinical Nutrition and IV drugs. The company offers a variety of phlebotomy products, including needles, transfer needles, and syringes with needles. Some of the main brands of Fresenius Kabi are Venofix, Venofix Safety, Venoject and Clave.
Key Companies in the Phlebotomy Equipment Market Include
- BD Diagnostics
- Becton, Dickinson and Company
- Cardinal Health
- Terumo Medical Corporation
- Beckman Coulter
- Roche Holding AG
- BioRad Laboratories
- Eppendorf AG
- Danaher Corporation
- BD (Becton, Dickinson and Company)
- Abbott
- Hologic
- Qiagen
- PerkinElmer
- Thermo Fisher Scientific
- Sysmex Corporation
- Greiner BioOne International
Phlebotomy Equipment Market Industry Developments
The Phlebotomy Equipment Market is projected to reach USD 13.3 billion by 2032, exhibiting a CAGR of 5.42% during the forecast period (2024-2032). The increasing prevalence of chronic diseases, rising demand for blood transfusions, and technological advancements in phlebotomy equipment are driving market growth. Key industry participants include Becton, Dickinson and Company, Terumo Medical Corporation, and Smiths Medical. Recent developments include the launch of new products such as the BD Vacutainer Eclipse™ Blood Collection Needle and the Terumo Surflo™ Winged Infusion Set. Market expansion is also being fueled by the growing adoption of point-of-care testing and the increasing focus on patient safety.
Phlebotomy Equipment Market Segmentation Insights
- Phlebotomy Equipment Market Product Type Outlook
- Blood Collection Tubes
- Needles
- Syringes
- Blood Collection Bags
- Safety Lancets
- Phlebotomy Equipment Market End User Outlook
- Hospitals
- Clinics
- Diagnostic Laboratories
- Blood Banks
- Research Laboratories
- Phlebotomy Equipment Market Material Outlook
- Plastic
- Glass
- Stainless Steel
- Phlebotomy Equipment Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
Report Attribute/Metric |
Details |
Market Size 2022 |
7.85 (USD Billion) |
Market Size 2023 |
8.27 (USD Billion) |
Market Size 2032 |
13.3 (USD Billion) |
Compound Annual Growth Rate (CAGR) |
5.42% (2024 - 2032) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Base Year |
2023 |
Market Forecast Period |
2024 - 2032 |
Historical Data |
2019 - 2023 |
Market Forecast Units |
USD Billion |
Key Companies Profiled |
BD Diagnostics, Becton, Dickinson and Company, Cardinal Health, Terumo Medical Corporation, Beckman Coulter, Roche Holding AG, BioRad Laboratories, Eppendorf AG, Danaher Corporation, BD (Becton, Dickinson and Company), Abbott, Hologic, Qiagen, PerkinElmer, Thermo Fisher Scientific, Sysmex Corporation, Greiner BioOne International |
Segments Covered |
Product Type, End User, Material, Regional |
Key Market Opportunities |
Increasing preference for safety devices Technological advancements Growing prevalence of chronic diseases Expansion into emerging markets Rising demand for point-of-care testing |
Key Market Dynamics |
Increasing demand for blood tests Technological advancements Rising prevalence of chronic diseases |
Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Phlebotomy Equipment Market size was valued at USD 8.27 billion in 2023 and is projected to reach USD 13.3 billion by 2032, exhibiting a CAGR of 5.42% during the forecast period.
North America is expected to dominate the Phlebotomy Equipment Market throughout the forecast period. The region's dominance can be attributed to the presence of a large number of hospitals, clinics, and diagnostic centers, as well as favorable reimbursement policies.
The increasing prevalence of chronic diseases, the rising geriatric population, and the growing demand for minimally invasive procedures are the major factors driving the growth of the Phlebotomy Equipment Market.
Phlebotomy Equipment is primarily used for blood collection and processing. It is widely used in hospitals, clinics, diagnostic centers, and blood banks for various applications such as blood tests, transfusions, and research purposes.
The key competitors in the Phlebotomy Equipment Market include Becton, Dickinson and Company, Terumo Corporation, Abbott Laboratories, Nipro Corporation, and Sarstedt AG.
The Phlebotomy Equipment Market in the Asia Pacific region is expected to grow at a CAGR of 6.2% during the forecast period. The growth is attributed to the increasing healthcare expenditure, the rising prevalence of chronic diseases, and the growing awareness about the importance of regular health check-ups.